Back to community news

New Clinical Trial- Would you like to take part?

No Image Description
A new clinical trial conducted by the Canadian Cancer Society-funded Canadian Cancer Trials Group (CCTG) is the first in the world to test an immune-stimulating treatment to reduce symptoms and prevent severe cases of COVID-19 and other serious respiratory infections specifically in people with cancer.

The trial is taking place at the Ottawa Hospital Cancer Centre (Ottawa), Odette Cancer Centre at Sunnybrook Health Sciences Centre (Toronto), Princess Margaret Cancer Centre (Toronto), Juravinski Cancer Centre (Hamilton), London Regional Cancer Program (London), Cedars Cancer Centre (Montreal), Centre Hospitalier de l'Université de Montréal (Montreal) and BC Cancer Agency (Vancouver). 

If you are interested in taking part in the trial, please speak to your oncologist. More information about the trial is available here.



IMM-101 clinical trial - could you please share the eligibility requirements for this trial?  Thank you.
  • Posted Mon 07 Sep 2020 02:57 PM EDT
Hi Elisi13,  I read more about the trial. It looks like criteria for inclusion includes those with a tumor mass or forms of cancer other than Breast Cancer.  The point of administration of the trial drug would be prior to start of treatment.  I am on treatment but not on chemo, and my cancer diagnosis is 4th stage breast cancer with mets to L4 bone.  So I don't think I'd be eligible.  I think the trail description should be more specific about criteria for inclusion.
  • Posted Tue 08 Sep 2020 10:02 PM EDT
The first sentence at the top, perhaps it should end with..." in people who are actively undergoing cancer treatment." 
 Do you think that would be better?
  • Posted Tue 08 Sep 2020 07:51 PM EDT

Log in or Register to post a comment.